Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulaglutide for Prevention of Perioperative Stress Hyperglycemia
NCT04862234Phase 4Terminated
- Sponsor
- Emory University
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dulaglutide biosimilar 14028 injection in Stress Hyperglycemia (SH), sponsored by Emory University. Started Aug 2021; status: terminated.
02
Drugs
dulaglutide biosimilar 14028 injection
03
Conditions
Stress Hyperglycemia (SH)
Beyond the preview
Go deeper on NCT04862234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04862234.